Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE) two randomised, double-masked,...

Heier Jeffrey S., Khanani Arshad M., Ruiz Carlos Quezada, Basu Karen, Ferrone Philip J., Brittain Christopher, Figueroa Marta S., Lin Hugh, Holz Frank G., Patel Vaibhavi, Lai Timothy Y. Y., Silverman David, Tóth-Molnár Edit, Zatorska Barbara, Kollaborációs szervezet: TENAYA and LUCERNE Investigators
2022

Real-World Safety and Effectiveness of Voretigene Neparvovec Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study /

Fischer M. Dominik, Simonelli Francesca, Sahni Jayashree, Holz Frank G., Maier Rainer, Fasser Christina, Suhner Andrea, Stiehl Daniel P., Chen Bee, Audo Isabelle, Leroy Bart P., Khan Arif O., Tóth-Molnár Edit, Nagy Zoltán Zsolt, Kollaborációs szervezet: PERCEIVE Study Group, et al
2024